5,8,11,14-eicosatetraynoic acid has been researched along with losartan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gelband, CH; Posner, P; Sumners, C; Zhu, M | 1 |
| Bautista, R; Escalante, B; Hernández, J; Oyekan, A; Sánchez, A | 1 |
2 other study(ies) available for 5,8,11,14-eicosatetraynoic acid and losartan
| Article | Year |
|---|---|
Chronotropic effect of angiotensin II via type 2 receptors in rat brain neurons.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; 5,8,11,14-Eicosatetraynoic Acid; Action Potentials; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Arachidonic Acids; Brain; Cytarabine; Enzyme Inhibitors; Imidazoles; Lipoxygenase; Lipoxygenase Inhibitors; Losartan; Nerve Tissue Proteins; Neurons; Okadaic Acid; Phosphoprotein Phosphatases; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Signal Transduction; Synaptic Transmission; Tetrodotoxin; Time Factors | 2001 |
Angiotensin II type AT(2) receptor mRNA expression and renal vasodilatation are increased in renal failure.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 5,8,11,14-Eicosatetraynoic Acid; Angiotensin II; Animals; Antihypertensive Agents; Arachidonic Acid; Clotrimazole; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Gene Expression Regulation; Imidazoles; In Vitro Techniques; Indomethacin; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Oligopeptides; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renal Insufficiency; RNA, Messenger; Vasodilation | 2001 |